Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
SONN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.38 - $18.71
Previous CloseN/A
Volume154.24K
Average Volume (3M)219.39K
Market Cap
$4.69M
Enterprise Value$4.33M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.33
Next Earnings
May 20, 2025EPS Estimate
-0.79Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-11.31
Shares Outstanding3,065,701
10 Day Avg. Volume88,727
30 Day Avg. Volume219,393
Standard Deviation0.28
R-Squared0.03
Alpha-0.12
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.69
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit232.57
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Sonnet BioTherapeutics Holdings News
---
Ownership Overview
7.36% Insiders
0.23% Mutual Funds
1.30% Other Institutional Investors
91.05% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SONN FAQ
What was Sonnet BioTherapeutics Holdings’s price range in the past 12 months?
Sonnet BioTherapeutics Holdings lowest stock price was $1.38 and its highest was $18.71 in the past 12 months.
What is Sonnet BioTherapeutics Holdings’s market cap?
Sonnet BioTherapeutics Holdings’s market cap is $4.69M.
When is Sonnet BioTherapeutics Holdings’s upcoming earnings report date?
Sonnet BioTherapeutics Holdings’s upcoming earnings report date is May 20, 2025 which is in 88 days.
How were Sonnet BioTherapeutics Holdings’s earnings last quarter?
Sonnet BioTherapeutics Holdings released its earnings results on Feb 13, 2025. The company reported -$1.56 earnings per share for the quarter, missing the consensus estimate of -$1.39 by -$0.17.
Is Sonnet BioTherapeutics Holdings overvalued?
According to Wall Street analysts Sonnet BioTherapeutics Holdings’s price is currently Overvalued.
Does Sonnet BioTherapeutics Holdings pay dividends?
Sonnet BioTherapeutics Holdings does not currently pay dividends.
What is Sonnet BioTherapeutics Holdings’s EPS estimate?
Sonnet BioTherapeutics Holdings’s EPS estimate is -0.79.
How many shares outstanding does Sonnet BioTherapeutics Holdings have?
Sonnet BioTherapeutics Holdings has 3,065,701 shares outstanding.
What happened to Sonnet BioTherapeutics Holdings’s price movement after its last earnings report?
Sonnet BioTherapeutics Holdings reported an EPS of -$1.56 in its last earnings report, missing expectations of -$1.39. Following the earnings report the stock price went down -1.282%.
Which hedge fund is a major shareholder of Sonnet BioTherapeutics Holdings?
Currently, no hedge funds are holding shares in SONN
---
Company Description
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics (NASDAQ:SONN) is a clinical-stage biotechnology company that is focused on the development of drugs for the treatment of cancer.
---
SONN Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Cyclacel Pharmaceuticals
―
Molecular Templates
―
Cellectar Biosciences
―
ADC Therapeutics
―
Best Analysts Covering SONN
1 Year
1 Year Success Rate
0/17 ratings generated profit
1 Year Average Return
-81.85%
reiterated a buy rating 6 months ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -81.85% per trade.
---